Nasal Polyps

Definition | Aetiology | Pathophysiology | Risk Factors | Signs and Symptoms | Investigations | Management

Definition

Nasal polyps are benign, inflammatory swellings of the nasal mucosa, typically arising from the paranasal sinuses, leading to nasal obstruction and other associated symptoms.

Aetiology

  • Chronic inflammation: associated with conditions such as asthma, allergic rhinitis, and chronic rhinosinusitis.
  • Aspirin exacerbated respiratory disease (AERD): characterised by nasal polyps, asthma, and aspirin sensitivity.
  • Genetic predisposition: familial tendencies in some cases.
  • Cystic fibrosis: nasal polyps are common in children with cystic fibrosis.

Pathophysiology

  • Chronic mucosal inflammation leads to oedema, proliferation of fibroblasts, and increased glandular secretions.
  • Polyp formation results in obstruction of nasal passages and impaired mucociliary clearance.
  • Histologically, polyps show eosinophilic infiltration and oedematous stroma.

Risk Factors

  • Asthma.
  • Allergic rhinitis.
  • Chronic rhinosinusitis.
  • Aspirin sensitivity.
  • Cystic fibrosis.

Signs and Symptoms

  • Nasal obstruction: bilateral blockage affecting airflow.
  • Rhinorrhoea: persistent nasal discharge.
  • Hyposmia or anosmia: reduced or absent sense of smell.
  • Postnasal drip: sensation of mucus dripping down the throat.
  • Facial pressure or headache: due to sinus involvement.
  • Mouth breathing: common in severe cases.

Investigations

  • Anterior rhinoscopy: visualises polyps in the nasal cavity.
  • Nasal endoscopy: provides detailed assessment of polyp location and severity.
  • CT scan of sinuses: evaluates extent of disease and sinus involvement.
  • Allergy testing: identifies potential allergic triggers.
  • Genetic testing: for cystic fibrosis in paediatric cases with recurrent polyps.

Management

1. Medical Treatment:

  • Intranasal corticosteroids: first line treatment (e.g., mometasone, fluticasone).
  • Oral corticosteroids: for severe cases or acute exacerbations.
  • Antihistamines: if allergic rhinitis is present.
  • Leukotriene receptor antagonists: in aspirin-exacerbated respiratory disease.

2. Surgical Management:

  • Endoscopic sinus surgery: indicated for large or refractory polyps.
  • Polypectomy: removes obstructive polyps but has a high recurrence rate.

3. Long-Term Management:

  • Regular use of intranasal corticosteroids to prevent recurrence.
  • Saline nasal irrigation to improve mucosal clearance.

4. Referral:

  • ENT specialist: for persistent or recurrent nasal polyps.
  • Respiratory specialist: if associated with severe asthma or AERD.
  • Genetics: if cystic fibrosis is suspected in children.